Guest Mark Bard, co-founder of the Digital Health Coalition (see Bio), discusses some of the key findings from the October 2012 member survey, "Voice of The DHC Membership," conducted among 61 members of the Coalition.
Despite Perceiving Current Risks as Outweighing Benefit, Nearly 80% of The Pharmaceutical and Device Industry Plans to Allocate More Marketing Budget to Social Media in 2013.
At the 6th Annual Digital Pharma East conference, the Digital Health Coalition -- a non-profit industry think tank focused on facilitating innovation in healthcare -- hosted more than 100 members of the healthcare industry, including patient advocates and representatives from the FDA, for an afternoon summit to share, educate and discuss current trends facing the industry in social media and mobile media. As part of the event, the Digital Health Coalition released summary findings of the DHC 2012 Executive Landscape Study.
"With 100% of pharma reporting they are either somewhat or very far behind in social media, the only way we are going to be able to move the industry forward is through sharing best practices and practical solutions," said Joe Farris, co-founder of the Digital Health Coalition, "and as we heard this week, patients are growing impatient with pharma companies choosing not to participate in social media."
Who are the members of the DHC?
Tell us about this survey. How many responses did you collect? Tell us about the respondents.
What were some of the key findings and what implications for pharmaceutical marketing can be drawn from these findings?
Mark Bard is a new media, marketing, and technology entrepreneur. In addition to personal ventures, he also invests in early stage technology and digital health startups taking an active advisory role with founders. With deep expertise in the digital health space, Mark's focus and passion includes mobile, social, search, and customer service in a digital world. With over 15 years of industry experience, Mark is an internationally recognized expert on topics including the Internet and the healthcare system, new media, health information technology trends, mobile, social, and pharmaceutical sales and marketing.